{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01872624",
      "OrgStudyIdInfo": {
        "OrgStudyId": "13-0150"
      },
      "Organization": {
        "OrgFullName": "Hospital de Clinicas de Porto Alegre",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Safety Study of Bone-marrow Derived Mesenchymal Stromal Cells Associated With Endobronchial Valves in Emphysema",
      "OfficialTitle": "Bone-marrow Derived Mesenchymal Stromal Cells Associated With One-way Endobronchial Valves in Patients With Pulmonary Emphysema: Safety Study"
    },
    "StatusModule": {
      "StatusVerifiedDate": "March 2015",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "May 2013"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "December 2014",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "March 2015",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "June 5, 2013",
      "StudyFirstSubmitQCDate": "June 5, 2013",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "June 7, 2013",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "March 24, 2015",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "March 25, 2015",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Hugo Goulart de Oliveira",
        "ResponsiblePartyInvestigatorTitle": "Associate Professor",
        "ResponsiblePartyInvestigatorAffiliation": "Hospital de Clinicas de Porto Alegre"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Hospital de Clinicas de Porto Alegre",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Ministry of Health, Brazil",
            "CollaboratorClass": "OTHER_GOV"
          },
          {
            "CollaboratorName": "National Research Council, Brazil",
            "CollaboratorClass": "OTHER"
          },
          {
            "CollaboratorName": "Conselho Nacional de Desenvolvimento Científico e Tecnológico",
            "CollaboratorClass": "OTHER_GOV"
          },
          {
            "CollaboratorName": "Rio de Janeiro State Research Supporting Foundation (FAPERJ)",
            "CollaboratorClass": "OTHER_GOV"
          },
          {
            "CollaboratorName": "Universidade Federal do Rio de Janeiro",
            "CollaboratorClass": "OTHER"
          },
          {
            "CollaboratorName": "Pontifícia Universidade Católica do Paraná",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The combined use of one-way endobronchial valves and bone-marrow derived mesenchymal stromal cells in patients with severe pulmonary emphysema is safe and will contribute to increase quality of life.",
      "DetailedDescription": "In addition to testing the safety of one-way endobronchial valves combined with bone-marrow derived mesenchymal stromal cells, the study will determine the systemic inflammatory potential of cell therapy measured by C-reactive protein levels (CRP), erythrocyte sedimentation rate (ESR) and complete blood count in peripheral blood. Finally, the study will aim at determining if other markers of inflammatory response and remodeling are modulated by this therapy."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Pulmonary Emphysema"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Not Applicable"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Non-Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "10",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Valves plus cells",
            "ArmGroupType": "Active Comparator",
            "ArmGroupDescription": "Bronchoscopy Five patients will be selected to receive bone-marrow derived mesenchymal stromal cells delivered bronchoscopically right before insertion of one-way endobronchial valves.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Procedure: Bronchoscopy"
              ]
            }
          },
          {
            "ArmGroupLabel": "Valves plus saline",
            "ArmGroupType": "Placebo Comparator",
            "ArmGroupDescription": "Bronchoscopy Five patients will be selected for treatment with one-way endobronchial valves only, with saline injected prior to valve insertion.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Procedure: Bronchoscopy"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Procedure",
            "InterventionName": "Bronchoscopy",
            "InterventionDescription": "Bronchoscopic delivery of one-way valves and bone-marrow derived mesenchymal stromal cells.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Valves plus cells",
                "Valves plus saline"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Absence of lung deficits during the procedure and/or in the 4 months follow-up",
            "PrimaryOutcomeTimeFrame": "4 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Quality of Life",
            "SecondaryOutcomeDescription": "St. George Respiratory Questionnaire",
            "SecondaryOutcomeTimeFrame": "120 days"
          },
          {
            "SecondaryOutcomeMeasure": "Pulmonary function",
            "SecondaryOutcomeDescription": "Spirometry, flow-volume curve, post-bronchodilator test, determination of residual volume, airway resistance by plethysmography, diffusing capacity of the lung for carbon monoxide, and six-minute walk test",
            "SecondaryOutcomeTimeFrame": "120 days"
          },
          {
            "SecondaryOutcomeMeasure": "Inflammation",
            "SecondaryOutcomeDescription": "Collection of blood samples for determination of C-reactive protein (CRP), erythrocyte",
            "SecondaryOutcomeTimeFrame": "120 days"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nDiagnosis of severe heterogeneous emphysema (heterogeneity > 15%), with heterogeneity defined as the difference between lobes in the percent area covered by parenchymal density greater than -950 Hounsfield Units.\nEstimation of collateral ventilation based on fissure with integrity ≥ 75%.\nTotal lung capacity> 100% predicted.\nResidual volume> 150% predicted.\nForced expiratory volume at the first minute <45% predicted.\nDiffusing capacity of the lungs for carbon monoxide <45% predicted.\nOptimal medical treatment.\nLimitations in daily physical activities.\nMinimum of 4 months without smoking\nHaving family support.\nStage ≥ 2 in modified Medical Research Council Dyspnea Scale (MMRC).\n\nExclusion Criteria:\n\nHomogenous emphysema.\nPresence of collateral ventilation.\nUse of systemic corticosteroids (prednisone> 20mg/day or equivalent).\nPulmonary or extrapulmonary infection.\nCoronary heart disease and/or severe ventricular dysfunction.\nSignificant renal or liver disease.\nImmunosuppressive disease.\nActive smoking.\nCancer prognosis with survival <2 years.\nPsychosocial problems.\nPregnancy.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Hugo G Oliveira, MD, PhD",
            "OverallOfficialAffiliation": "Hospital de Clínicas de Porto Alegre",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Patricia RM Rocco, MD, PhD",
            "OverallOfficialAffiliation": "Universidade Federal do Rio de Janeiro",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Pontificia Universidade Catolica do Parana",
            "LocationCity": "Curitiba",
            "LocationState": "PR",
            "LocationZip": "80215-901",
            "LocationCountry": "Brazil"
          },
          {
            "LocationFacility": "Universidade Federal do Rio de Janeiro",
            "LocationCity": "Rio de Janeiro",
            "LocationState": "RJ",
            "LocationZip": "21941-902",
            "LocationCountry": "Brazil"
          },
          {
            "LocationFacility": "Hospital de Clínicas de Porto Alegre",
            "LocationCity": "Porto Alegre",
            "LocationState": "RS",
            "LocationZip": "90035-003",
            "LocationCountry": "Brazil"
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "21656291",
            "ReferenceType": "background",
            "ReferenceCitation": "Abreu SC, Antunes MA, Pelosi P, Morales MM, Rocco PR. Mechanisms of cellular therapy in respiratory diseases. Intensive Care Med. 2011 Sep;37(9):1421-31. doi: 10.1007/s00134-011-2268-3. Epub 2011 Jun 9. Review."
          },
          {
            "ReferencePMID": "16840401",
            "ReferenceType": "background",
            "ReferenceCitation": "de Oliveira HG, Macedo-Neto AV, John AB, Jungblut S, Prolla JC, Menna-Barreto SS, Fortis EA. Transbronchoscopic pulmonary emphysema treatment: 1-month to 24-month endoscopic follow-up. Chest. 2006 Jul;130(1):190-9."
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000011656",
            "ConditionMeshTerm": "Pulmonary Emphysema"
          },
          {
            "ConditionMeshId": "D000004646",
            "ConditionMeshTerm": "Emphysema"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000029424",
            "ConditionAncestorTerm": "Pulmonary Disease, Chronic Obstructive"
          },
          {
            "ConditionAncestorId": "D000008173",
            "ConditionAncestorTerm": "Lung Diseases, Obstructive"
          },
          {
            "ConditionAncestorId": "D000008171",
            "ConditionAncestorTerm": "Lung Diseases"
          },
          {
            "ConditionAncestorId": "D000012140",
            "ConditionAncestorTerm": "Respiratory Tract Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M13662",
            "ConditionBrowseLeafName": "Pulmonary Emphysema",
            "ConditionBrowseLeafAsFound": "Pulmonary Emphysema",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M6964",
            "ConditionBrowseLeafName": "Emphysema",
            "ConditionBrowseLeafAsFound": "Emphysema",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M10320",
            "ConditionBrowseLeafName": "Lung Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M22602",
            "ConditionBrowseLeafName": "Pulmonary Disease, Chronic Obstructive",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10322",
            "ConditionBrowseLeafName": "Lung Diseases, Obstructive",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14129",
            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC08",
            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          }
        ]
      }
    }
  }
}